Talus Bio Email Format

Biotechnology ResearchWashington, United States11-50 Employees

Talus Bio is a biotechnology research company focused on the regulome, aiming to make it visible and druggable. It is building a platform to map and model the regulome with the intention of unlocking targets that have been difficult to drug, including transcription factors linked to cancer, autoimmunity, and neurodegeneration. The platform measures the regulome directly in living human cells, producing functional datasets at scale that inform AI models about genome regulation and how to modulate it with precision. 
 
Based in Seattle, Washington, the company was founded in 2020 and operates as a small to mid-sized team. Its offerings are directed at researchers and biotechnology developers seeking to identify and therapeutically target transcription factors and other regulators of gene expression. In 2025, Talus Bio presented preclinical data on transcription factor therapeutic programs at the AACR Annual Meeting, reflecting a concrete advance in its research program.

Sign up for free to view info

Company overview Employee directory